Myopia is guilty, is it justified to take off the mirror? Aier Ophthalmology was fined for violating the Advertising Law. Netizens: Please treat yourself first! -Finance-financial world Post date May 20, 2022 — 17:39 Post Lock Read More Tongce Medical intends to "bit the teeth" to acquire Heren Technology Post date May 17, 2022 — 10:12 Post Lock Read More Zhongheng Group: The company's pharmaceutical research and development direction is mainly concentrated in the field of traditional Chinese medicine research and development, mainly in the fields of cardiovascular and cerebrovascular, classic traditional Chinese medicine and other fields Post date May 17, 2022 — 09:30 Post Lock Read More Industry and people's livelihood go hand in hand Post date May 16, 2022 — 20:35 Post Lock Read More The financing balance of GEM companies decreased by 705 million yuan during the three consecutive declines_Oriental Fortune Net Post date May 16, 2022 — 11:24 Post Lock Read More He's Ophthalmology: Optometry stores cannot directly sell atropine Post date May 13, 2022 — 22:09 Post Lock Read More He's Ophthalmology: The company does not have violations of laws and regulations such as manipulating stock prices Post date May 13, 2022 — 22:02 Post Lock Read More Who is more attractive after the callback? Comparison of the four major indicators of Mao index and Ning combination Post date May 13, 2022 — 08:53 Post Lock Read More Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys Post date May 12, 2022 — 20:16 Post Lock Read More The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Tongce Medical intends to "bit the teeth" to acquire Heren Technology Post date May 17, 2022 — 10:12 Post Lock Read More Zhongheng Group: The company's pharmaceutical research and development direction is mainly concentrated in the field of traditional Chinese medicine research and development, mainly in the fields of cardiovascular and cerebrovascular, classic traditional Chinese medicine and other fields Post date May 17, 2022 — 09:30 Post Lock Read More Industry and people's livelihood go hand in hand Post date May 16, 2022 — 20:35 Post Lock Read More The financing balance of GEM companies decreased by 705 million yuan during the three consecutive declines_Oriental Fortune Net Post date May 16, 2022 — 11:24 Post Lock Read More He's Ophthalmology: Optometry stores cannot directly sell atropine Post date May 13, 2022 — 22:09 Post Lock Read More He's Ophthalmology: The company does not have violations of laws and regulations such as manipulating stock prices Post date May 13, 2022 — 22:02 Post Lock Read More Who is more attractive after the callback? Comparison of the four major indicators of Mao index and Ning combination Post date May 13, 2022 — 08:53 Post Lock Read More Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys Post date May 12, 2022 — 20:16 Post Lock Read More The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongheng Group: The company's pharmaceutical research and development direction is mainly concentrated in the field of traditional Chinese medicine research and development, mainly in the fields of cardiovascular and cerebrovascular, classic traditional Chinese medicine and other fields Post date May 17, 2022 — 09:30 Post Lock Read More Industry and people's livelihood go hand in hand Post date May 16, 2022 — 20:35 Post Lock Read More The financing balance of GEM companies decreased by 705 million yuan during the three consecutive declines_Oriental Fortune Net Post date May 16, 2022 — 11:24 Post Lock Read More He's Ophthalmology: Optometry stores cannot directly sell atropine Post date May 13, 2022 — 22:09 Post Lock Read More He's Ophthalmology: The company does not have violations of laws and regulations such as manipulating stock prices Post date May 13, 2022 — 22:02 Post Lock Read More Who is more attractive after the callback? Comparison of the four major indicators of Mao index and Ning combination Post date May 13, 2022 — 08:53 Post Lock Read More Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys Post date May 12, 2022 — 20:16 Post Lock Read More The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Industry and people's livelihood go hand in hand Post date May 16, 2022 — 20:35 Post Lock Read More The financing balance of GEM companies decreased by 705 million yuan during the three consecutive declines_Oriental Fortune Net Post date May 16, 2022 — 11:24 Post Lock Read More He's Ophthalmology: Optometry stores cannot directly sell atropine Post date May 13, 2022 — 22:09 Post Lock Read More He's Ophthalmology: The company does not have violations of laws and regulations such as manipulating stock prices Post date May 13, 2022 — 22:02 Post Lock Read More Who is more attractive after the callback? Comparison of the four major indicators of Mao index and Ning combination Post date May 13, 2022 — 08:53 Post Lock Read More Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys Post date May 12, 2022 — 20:16 Post Lock Read More The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The financing balance of GEM companies decreased by 705 million yuan during the three consecutive declines_Oriental Fortune Net Post date May 16, 2022 — 11:24 Post Lock Read More He's Ophthalmology: Optometry stores cannot directly sell atropine Post date May 13, 2022 — 22:09 Post Lock Read More He's Ophthalmology: The company does not have violations of laws and regulations such as manipulating stock prices Post date May 13, 2022 — 22:02 Post Lock Read More Who is more attractive after the callback? Comparison of the four major indicators of Mao index and Ning combination Post date May 13, 2022 — 08:53 Post Lock Read More Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys Post date May 12, 2022 — 20:16 Post Lock Read More The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
He's Ophthalmology: Optometry stores cannot directly sell atropine Post date May 13, 2022 — 22:09 Post Lock Read More He's Ophthalmology: The company does not have violations of laws and regulations such as manipulating stock prices Post date May 13, 2022 — 22:02 Post Lock Read More Who is more attractive after the callback? Comparison of the four major indicators of Mao index and Ning combination Post date May 13, 2022 — 08:53 Post Lock Read More Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys Post date May 12, 2022 — 20:16 Post Lock Read More The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
He's Ophthalmology: The company does not have violations of laws and regulations such as manipulating stock prices Post date May 13, 2022 — 22:02 Post Lock Read More Who is more attractive after the callback? Comparison of the four major indicators of Mao index and Ning combination Post date May 13, 2022 — 08:53 Post Lock Read More Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys Post date May 12, 2022 — 20:16 Post Lock Read More The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Who is more attractive after the callback? Comparison of the four major indicators of Mao index and Ning combination Post date May 13, 2022 — 08:53 Post Lock Read More Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys Post date May 12, 2022 — 20:16 Post Lock Read More The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys Post date May 12, 2022 — 20:16 Post Lock Read More The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The main trend: the net outflow of extra large orders was 12.783 billion yuan on May 12_Oriental Fortune Net Post date May 12, 2022 — 18:16 Post Lock Read More Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released Post date May 11, 2022 — 23:51 Post Lock Read More 3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
3000 points of repeated sawing! Can medical beauty concept stocks still become the target of hot speculation? Post date May 11, 2022 — 21:33 Post Lock Read More Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission. Post date May 11, 2022 — 20:31 Post Lock Read More The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The balance of financing of 138 shares increased by more than 5% _ Oriental Fortune Net Post date May 11, 2022 — 11:19 Post Lock Read More Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Aier Ophthalmology responded to Aier Ophthalmology after the stock price fell 10.70%_Sina Finance_Sina.com Post date May 9, 2022 — 20:47 Post Lock Read More After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
After the stock price plummeted 10.70%, Aier Ophthalmology responded Post date May 9, 2022 — 20:39 Post Lock Read More "Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
"Eyes" Aier Ophthalmology once fell by more than 10%, and the medical service sector weakened collectively. Post date May 9, 2022 — 16:07 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Set up a special fund of 10 billion yuan! "China Optics Valley" invests heavily in the innovative drug track Post date May 9, 2022 — 02:04 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More
Caishen.CoCaishen.Co